Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats

Overview of attention for article published in Drug Design, Development and Therapy, November 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 34 publications that cite this research output.

34

The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.

Relationship of mTORC1 and ferroptosis in tumors

Article in Discover Oncology (April 2024)

Enhanced Antipediatric Sarcoma Effect of Everolimus with Secukinumab by Targeting IL17A.

Article in Molecular Cancer Therapeutics (January 2024)

Edaravone and obeticholic acid protect against cisplatin-induced heart toxicity by suppressing oxidative stress and inflammation and modulating Nrf2, TLR4/p38MAPK, and JAK1/STAT3/NF-κB signals

Article in Naunyn-Schmiedeberg's Archives of Pharmacology (January 2024)